Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1986;64(6):775–786.

A century of progress in combating yellow fever*

P L J Brès
PMCID: PMC2490971  PMID: 3549030

Abstract

Yellow fever was responsible for several epidemics among the settlers in tropical areas of the Americas and Africa during the 17th to the 19th centuries. Scientific research into its cause and epidemiology was started at the beginning of the present century and progressed well ahead of other viral disease research. However, epidemics still occur and the worst one ever recorded was in Ethiopia in 1960-62. Epidemiological research has recently provided new findings on the ecology of the virus and the risk of epidemics. Recent breakthroughs in the molecular study of the virus should provide new tools for further progress in treatment and control of the disease. Meanwhile, the risk of urbanization of the disease, deficiencies in treatment, limitations in vector control, and erratic policies in preventive immunization present real problems.

Full text

PDF
775

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Lhuillier M., Sarthou J. L., Cordellier R., Monteny N., Gershy-Damet G. M., Bouchite B. Emergence endémique de la fièvre jaune en Côte d'Ivoire: place de la détection des IgM antiamariles dans la stratégie de surveillance. Bull World Health Organ. 1986;64(3):415–420. [PMC free article] [PubMed] [Google Scholar]
  2. Monath T. P., Nystrom R. R. Detection of yellow fever virus in serum by enzyme immunoassay. Am J Trop Med Hyg. 1984 Jan;33(1):151–157. doi: 10.4269/ajtmh.1984.33.151. [DOI] [PubMed] [Google Scholar]
  3. Rice C. M., Lenches E. M., Eddy S. R., Shin S. J., Sheets R. L., Strauss J. H. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science. 1985 Aug 23;229(4715):726–733. doi: 10.1126/science.4023707. [DOI] [PubMed] [Google Scholar]
  4. Schlesinger J. J., Brandriss M. W., Walsh E. E. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J Immunol. 1985 Oct;135(4):2805–2809. [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES